Ulrike Harms

680 total citations
12 papers, 527 citations indexed

About

Ulrike Harms is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Ulrike Harms has authored 12 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Surgery. Recurrent topics in Ulrike Harms's work include Neuroscience and Neuropharmacology Research (2 papers), Glioma Diagnosis and Treatment (2 papers) and Cell death mechanisms and regulation (2 papers). Ulrike Harms is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Glioma Diagnosis and Treatment (2 papers) and Cell death mechanisms and regulation (2 papers). Ulrike Harms collaborates with scholars based in Germany, United States and Slovakia. Ulrike Harms's co-authors include Christoph Harms, Matthias Endres, Ulrich Dirnagl, Heide Hörtnagl, Klaus Fink, Julian Bösel, Florin Gandor, Dirk Megow, Pierre Chryso Djoufack and Michael Synowitz and has published in prestigious journals such as Circulation, Journal of Neuroscience and Scientific Reports.

In The Last Decade

Ulrike Harms

12 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Harms Germany 11 263 100 80 67 65 12 527
Chengshi Xu China 15 224 0.9× 78 0.8× 52 0.7× 106 1.6× 93 1.4× 35 617
Keiichi Kadoyama Japan 13 272 1.0× 121 1.2× 65 0.8× 49 0.7× 58 0.9× 36 583
Meijuan Yan China 15 285 1.1× 61 0.6× 59 0.7× 55 0.8× 30 0.5× 50 503
Andrés A. Urrutia Spain 12 194 0.7× 75 0.8× 109 1.4× 117 1.7× 31 0.5× 21 480
Koei Shinzawa Japan 14 360 1.4× 113 1.1× 193 2.4× 39 0.6× 112 1.7× 20 755
Nuri Kim South Korea 15 327 1.2× 52 0.5× 109 1.4× 74 1.1× 52 0.8× 25 609
Zongmao Zhao China 17 360 1.4× 58 0.6× 44 0.6× 122 1.8× 74 1.1× 66 669
Permphan Dharmasaroja Thailand 14 228 0.9× 71 0.7× 45 0.6× 41 0.6× 133 2.0× 44 590
Dianer Yang United States 14 229 0.9× 53 0.5× 110 1.4× 97 1.4× 52 0.8× 16 562
Nicholas Beazley‐Long United Kingdom 12 286 1.1× 80 0.8× 42 0.5× 99 1.5× 35 0.5× 19 562

Countries citing papers authored by Ulrike Harms

Since Specialization
Citations

This map shows the geographic impact of Ulrike Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Harms more than expected).

Fields of papers citing papers by Ulrike Harms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Harms. The network helps show where Ulrike Harms may publish in the future.

Co-authorship network of co-authors of Ulrike Harms

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Harms. A scholar is included among the top collaborators of Ulrike Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Harms. Ulrike Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Piper, Sophie K., et al.. (2022). Mental health in myasthenia gravis patients and its impact on caregiver burden. Scientific Reports. 12(1). 19275–19275. 15 indexed citations
2.
Acker, Güliz, Sophie K. Piper, Thomas Broggini, et al.. (2018). Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma. Oncotarget. 9(45). 27760–27772. 1 indexed citations
3.
Donath, Stefan, Jing An, Karen Gertz, et al.. (2016). Interaction of ARC and Daxx: A Novel Endogenous Target to Preserve Motor Function and Cell Loss after Focal Brain Ischemia in Mice. Journal of Neuroscience. 36(31). 8132–8148. 13 indexed citations
4.
Broggini, Thomas, Christoph Harms, Jonas Blaes, et al.. (2015). NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment. Cancer Letters. 380(2). 568–576. 16 indexed citations
5.
Hoffmann, Christian J., Ulrike Harms, André Rex, et al.. (2015). Vascular Signal Transducer and Activator of Transcription-3 Promotes Angiogenesis and Neuroplasticity Long-Term After Stroke. Circulation. 131(20). 1772–1782. 76 indexed citations
6.
Czabanka, Marcus, Thomas Broggini, Simon Bayerl, et al.. (2013). Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas. European Journal of Cancer. 49(9). 2243–2252. 22 indexed citations
7.
Harms, Christoph, Frank Wiekhorst, Lutz Trahms, et al.. (2013). Certain Types of Iron Oxide Nanoparticles are Not Suited to Passively Target Inflammatory Cells that Infiltrate the Brain in Response to Stroke. Journal of Cerebral Blood Flow & Metabolism. 33(5). e1–e9. 26 indexed citations
8.
Harms, Christoph, Ulrike Harms, Kerstin Seidel, et al.. (2007). Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1as a Novel Mechanism of Neuroprotection by Glucocorticoids. Journal of Neuroscience. 27(17). 4562–4571. 57 indexed citations
9.
Meisel, Andreas, Christoph Harms, Ferah Yildirim, et al.. (2006). Inhibition of histone deacetylation protects wild‐type but not gelsolin‐deficient neurons from oxygen/glucose deprivation. Journal of Neurochemistry. 98(4). 1019–1031. 35 indexed citations
10.
Bösel, Julian, Florin Gandor, Christoph Harms, et al.. (2005). Neuroprotective effects of atorvastatin against glutamate‐induced excitotoxicity in primary cortical neurones. Journal of Neurochemistry. 92(6). 1386–1398. 173 indexed citations
11.
Harms, Christoph, Julian Bösel, Marion Lautenschlager, et al.. (2004). Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Molecular and Cellular Neuroscience. 25(1). 69–82. 69 indexed citations
12.
Kapinya, Krisztian, Ulrike Harms, Christoph Harms, et al.. (2003). Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo. Journal of Neurochemistry. 84(5). 1028–1039. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengshi Xu Breakdown of academic impact, for papers by Keiichi Kadoyama Breakdown of academic impact, for papers by Meijuan Yan Breakdown of academic impact, for papers by Andrés A. Urrutia Breakdown of academic impact, for papers by Koei Shinzawa Breakdown of academic impact, for papers by Nuri Kim Breakdown of academic impact, for papers by Zongmao Zhao Breakdown of academic impact, for papers by Permphan Dharmasaroja Breakdown of academic impact, for papers by Dianer Yang Breakdown of academic impact, for papers by Nicholas Beazley‐Long
Rankless by CCL
2026